Organonitrogen Compounds
eMolecules 6335-41-7 | 4-Methoxyisonitrosoacetanilide | ChemScene194.190 | C9H10N2O3 | 98.000 | COc1ccc(NC(=O)\C=N/O)cc1 | 100mg | 801476486
4-Methoxyisonitrosoacetanilide | ChemScene | 6335-41-7194.190 | C9H10N2O3 | 98.000 | COc1ccc(NC(=O)\C=N/O)cc1 | 100mg | 801476486
eMolecules 185122-63-8 | 5-Bromo-1-indanone oxime | Oakwood Chemical | MFCD22375203 | 226.073 | C9H8BrNO | 98.000 | O\N=C1\CCc2cc(Br)ccc12 | 1g | 537701636
5-Bromo-1-indanone oxime | Oakwood Chemical | 185122-63-8 | MFCD22375203 | 226.073 | C9H8BrNO | 98.000 | O\N=C1\CCc2cc(Br)ccc12 | 1g | 537701636
Medchemexpress LLC Biacetyl monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 10g
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
eMolecules 69113-32-2 | 4-FLUOROBENZAMIDOXIME | AstaTech | MFCD00216571 | 154.144 | C7H7FN2O | 97.000 | N\C(=N/O)c1ccc(F)cc1 | 5g | 268495761
4-FLUOROBENZAMIDOXIME | AstaTech | 69113-32-2 | MFCD00216571 | 154.144 | C7H7FN2O | 97.000 | N\C(=N/O)c1ccc(F)cc1 | 5g | 268495761
eMolecules 94-67-7 | Salicylaldoxime | Ambeed137.138 | C7H7NO2 | 95.000 | ON=Cc1ccccc1O | 5g | 552679801
Salicylaldoxime | Ambeed | 94-67-7137.138 | C7H7NO2 | 95.000 | ON=Cc1ccccc1O | 5g | 552679801
Aobchem 2 5-Difluorobenzaldehyde oxime | ≥97% | CAS 915768-14-8 | C7H5F2NO | 250mg
2 5-Difluorobenzaldehyde oxime | ≥97% | CAS 915768-14-8 | C7H5F2NO | 250mg
Cayman Chemical 2-PyrIdylamIde oxIme 250mg
A synthetic intermediate useful for pharmaceutical synthesis
Aobchem 2 5-Difluorobenzaldehyde oxime | ≥97% | CAS 915768-14-8 | C7H5F2NO | 500mg
2 5-Difluorobenzaldehyde oxime | ≥97% | CAS 915768-14-8 | C7H5F2NO | 500mg
Medchemexpress LLC 2,3-butanedione monoxime | 57-71-6 | MFCD00002116 | 98.0% | 101.10 g/mol | C4H7NO2 | 1mL
Biacetyl monoxime (Diacetyl monoxime) a myosin ATPase inhibitor is a skeletal and cardiac muscle contraction inhibitor Biacetyl monoxime is also a well-characterized non-competitive inhibitor of chemical and motile activity of skeletal muscle myosin-II Biacetyl monoxime induces sarcoplasmic reticulum Ca2 release[1][2][3]
Cayman Chemical 5 2AmInopyrIdylamIde oxIme 1g
5-(2-Aminopyridyl)amide oxime is a synthetic intermediate useful for pharmaceutical synthesis
Apexbio Technology LLC Indirubin-3'-oxime 160807-49-8 50mg
Indirubin-3 -oxime (CAS 160807-49-8) is a derivative of indirubin investigated primarily as an inhibitor of glycogen synthase kinase-3 (GSK-3 ) exhibiting an IC50 of approximately 22 nM This compound also inhibits CDK5/p25 and CDK1/cyclin B with IC50 values of around 100 nM and 180 nM respectively while demonstrating weaker inhibitory activity against 5-lipoxygenase (IC50 7 8 10 M) Due to its modulation of multiple kinases involved in cell signaling Indirubin-3 -oxime is widely utilized in research on cellular signaling pathways and the molecular mechanisms underlying disease
Sigma Aldrich Fine Chemicals Biosciences 2,3-Butanedione monoxime >=98% | 57-71-6 | MFCD00002116 | 500G
2,3-Butanedione monoxime >=98% | Purity: >=98% | Mol Wt: 101.1 | 57-71-6 | MFCD00002116 | 500G
Sigma Aldrich Fine Chemicals Biosciences 2,3-Butanedione monoxime >=98% | 57-71-6 | MFCD00002116 | 1KG
2,3-Butanedione monoxime >=98% | Purity: >=98% | Mol Wt: 101.1 | 57-71-6 | MFCD00002116 | 1KG